The A-Fib paper GOED has been working on for many months — a comparison of the risks and benefits of EPA and DHA omega-3 supplementation — has been accepted for publication in the peer-reviewed journal Value in Health. The pre-published proof, as well as the Pub Med link, are now available online. We expect the paper to be published in print in October.
This paper explored the impact of EPA and DHA supplementation on quality adjusted life years (QALY), a standard health economics measure used to compare the effectiveness of health-related interventions. The data show that omega-3 interventions at all dosages from 300-2,500 mg/day result in gains in QALYs, compared to usual care, and therefore the cardiovascular benefits associated with omega-3 intake outweigh the reported risk of A-fib. Supplementation with all dosages in this range was found to be cost-effective. GOED is working on specific talking points to share with members.
GOED is also planning a full public relations/communications campaign, complete with a consumer press release, media pitching and influencer and HCP outreach once the article is in print. In addition, we will be updating our A-Fib key messages document and working on talking points to aid in future discussions with global policymakers.
It is also worth noting that the additional A-Fib paper GOED has commissioned, the research for which is being done by GOED partner FARI, is expected to be submitted for publication in September, and the findings in this paper also reflect more positively on the overall A-fib story.
This publication comes at an important time, as the new issue of the German Federal Institute for Risk Assessment’s (BfR) science magazine, BfR2GO, has been published and the lead article focuses on food supplements and the widespread misconceptions about them. Of the five misunderstandings presented, the fifth one – “Food supplements are harmless,…” - mentions omega-3s as an example. Specifically, the article reads, “Food supplements…, may lead to undesired effects,… For instance, in persons with heart disease, products with omega-3 fatty acids may increase the risk of atrial fibrillation.” This position was first communicated in a 16 November 2023 letter to healthcare professionals.
For any questions about the GOED publication, please contact Aldo Bernasconi, VP of Data Science and lead author of the paper. Questions about the communications campaign should be directed to Elana Natker, Director of Consumer and Health Professional Communications.
Please note that GOED does not analyze or make any representation of accuracy for the Omega-3 News items. This is simply a compilation of news articles found on the internet that are relevant to the EPA and DHA business.
Highlights
First Anchovy Season in Peru Ends
The Peruvian anchovy fishing season in the North-Central zone has ended due to the high presence of juveniles. Approximately 82% of the quota was caught.
GOED Invited to EC Stakeholder Forum on Mineral Oil Hydrocarbons in Food Additives
GOED has received an invitation to participate in a European Commission (EC) stakeholder forum (3 October 2025) on mineral oil hydrocarbons (MOH) in food additives. The aim of the forum is to discuss the status of MOAH (mineral oil aromatic hydrocarbons) specifically in food additives, supported by new occurrence data from industry stakeholders. Last year, GOED submitted a letter pointing out the high matrix interference in MOH measurements in mixed tocopherols, precluding MOAH quantification in this food additive fundamental to omega-3 product stabilization.
We are asking members to share any significant progress made in the quantification of MOH in mixed tocopherols, or if any approaches to mitigate MOH and interferences in these antioxidant products have been developed. Please support your feedback with testing results. If there is nothing new to report, GOED will not present during the stakeholder forum, but we will request participation as a viewer. Please note that this request is only focused on mixed tocopherols. We continue to work separately on MOH initiatives in omega-3 oils. If you have any questions, please contact Gerard Bannenberg.
SupplySide Global: Buy an ad on the digital tower across from the Omega-3 Resource Center. Ads are US$1500 and play throughout the show. See 2025 sales flyer here.
Vitafoods Europe: The show will take place from May 5-7, 2026, in Barcelona, Spain, a new location last year that proved to be quite successful.See 2026 sales flyer here.
If you are interested in any of these opportunities, please contact Ashley Becnel.
Production & Supply Chain
GOED member Mara Renewables raised US$9 million (€7.7 million) in funding to expand its omega-3 manufacturing footprint and R&D capacity.
The United States Pharmacopeia-National Formulary/Pharmacopeial Forum (USP-NF/PF) has published a proposed revision to the Krill Oil Monograph in the Pharmacopeial Forum (PF), as part of PF 51(4), currently open for public comments until September 30.
The revision is based on the official monograph of May 1, 2025, and suggests updates to the upper limits in the identification acceptance criteria –specifically, the ratio of the area percentage of palmitic acid to myristic acid, and the area percentage of EPA. The proposed limits are 3.9 and 32.0, respectively (previously 3.6 and 28.0 area %).
Subscribers can access the proposal via the My Dashboard homepage by selecting PF 51(4) and locating the Krill Oil monograph or by searching for “krill oil” in the search bar, where the document will appear as the first result, identified with “Commenting open” in blue. Alternatively, anyone may view and comment on the proposal by registering for a free Pharmacopeial Forum Online account.
GOED offers connections for companies looking for omega-3 related solutions or partners. If you want to include an anonymous request, please contact Ashley Becnel.
A company is looking for 300-400 tons of fish oil and 500-600 tons of fish meal every month. [Posted 7/14/2025]
Korean health brand Daewoong Pharmaceuticals has launched Hap-sung, a multifunctional health supplement that combines astaxanthin, EPA and DHA omega-3 (600mg), magnesium, B vitamins, vitamin D, vitamin C and Lactobacillusinto a simple two-capsule daily dose. The formulation was designed to address consumer demand for convenience and reduce overlap in supplement intake.
GOED member dsm-firmenich's Health, Nutrition & Care APAC team has launched its Healthy Longevity platform in the region. The launch featured an exclusive seminar at the company’s Singapore facility, participation in the Growth Asia Summit and the debut of a vanilla-flavored capsule prototype containing life’sOMEGA and Quali-D.
GOED member Nestlé Health Science has opened its first store in South Korea, offering personalized supplement recommendations using digital health assessments. The store also features approximately 120 products from eight of its key brands.
GOED member Marine Stewardship Council (MSC) is inviting consumers to vote for their preferred MSC-certified seafood product for the MSC UK Product of the Year 2025. Among the nominees is GOED member Wiley’s Finest Peak EPA, a wild Alaskan fish oil supplement.
.png?upscale=true&width=1120&upscale=true&name=Omega-3%20News%20(1).png)
